Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy

References

• Dekker G, Sibai B. Primary, secondary and tertiary prevention of preeclampsia. Lancet. 2001; 357: 209–15. 10.1016/S0140-6736(00)03599-6
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders in pregnancy. Best Pract Res Clin Obstetrics Gynaecol. 2011; 25: 391–403. 10.1016/j.bpobgyn.2011.01.006
   PubMed Web of Science ®Google Scholar
• Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008; 52: 873–80. 10.1161/HYPERTENSIONAHA.108.117358
   PubMed Web of Science ®Google Scholar
• Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble FMS-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005; 57: 1R–7R. 10.1203/01.PDR.0000159567.85157.B7
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Rana S, Taylor RN. Chapter 6: angiogenesis and Preeclampsia. In Taylor R, Roberts J, Cunningham F, Lindheimer M (eds), Chesley’s hypertensive disorders in pregnancy. 4th edition. Elsevier, 2015
   Google Scholar
• De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D’anna R. EndoglinPlGF and sFlt-1 as markers for predicting preeclampsia. Acta Obstet Gynecol Scand. 2008; 87: 837–42. 10.1080/00016340802253759
   PubMed Web of Science ®Google Scholar
• Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013; 12819: 2121–3110.1161/CIRCULATIONAHA.113.003215
   PubMed Web of Science ®Google Scholar
• Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H. The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem. 2012; 585: 837–4510.1373/clinchem.2011.169094
   PubMed Web of Science ®Google Scholar
• Ahmad S. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004; 95: 884–91. 10.1161/01.RES.0000147365.86159.f5
   PubMed Web of Science ®Google Scholar
• Ramma W, Buhimschi IA, Zhao G, Dulay AT, Nayeri UA, Buhimschi CS, Ahmed A. The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis. 2012; 15: 333–40. 10.1007/s10456-012-9261-5
   PubMed Web of Science ®Google Scholar
• Crispi F, Domínguez C, Llurba E, Martín-Gallán P, Cabero L, Gratacós E. Placental angiogenic growth factors and uterine artery doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006; 195: 201–07. 10.1016/j.ajog.2006.01.014
   PubMed Web of Science ®Google Scholar
• Ahmed A, Ramma W. Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?. Br J Pharmacol. 2015; 172: 1574–86. 10.1111/bph.12977
   PubMed Web of Science ®Google Scholar
• Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I. et al. Induction of placental heme oxygenase-1 is protective against TNF alpha-induced cytotoxicity and promotes vessel relaxation. Mol Med. 2000; 6: 391–409
   PubMed Web of Science ®Google Scholar
• Linzke N, Schumacher A, Woidacki K, Croy BA, Zenclussen AC. Carbon monoxide promotes proliferation of uterine natural killer cells and remodelling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice. Hypertension. 2014; 63: 580–88. 10.1161/HYPERTENSIONAHA.113.02403
   PubMed Web of Science ®Google Scholar
• Ahmed A. Heparin-binding angiogenic growth factors in pregnancy. Trophoblast Res. 1998; 10: 215–58
   Google Scholar
• Zenclussen ML, Linzke N, Schumacher A, Fest S, Meyer N, Casalis PA, Zenclussen AC. Heme oxygenase-1 is critically involved in placentation, spiral artery Remodelling, and blood pressure regulation during murine pregnancy. Front Pharmacol. 2015; 5Article 291: 110.3389/fphar.2014.00291
   Google Scholar
• Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007; 115: 1789–97. 10.1161/CIRCULATIONAHA.106.660134
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. ISSHP. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from ISSHP. Pregnancy Hypertension. 2014; 4: 97–104. 10.1016/j.preghy.2014.02.001
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R, Edwin S. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 2004; 1906: 1541–47. 10.1016/j.ajog.2004.03.043
   PubMed Web of Science ®Google Scholar
• Wikström A-K, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 2007; 1096: 1368–74. 10.1097/01.AOG.0000264552.85436.a1
   PubMed Web of Science ®Google Scholar
• Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG. 2010; 117: 314–20. 10.1111/j.1471-0528.2010.02739.x
   PubMed Web of Science ®Google Scholar
• Miyagami S, Koide K, Sekizawa A, Ventura W, Yotsumoto J, Oishi S, Okai T. Physiological changes in the pattern of placental gene expression early in the first trimester. Reprod Sci. 2013; 20: 710–14. 10.1177/1933719112466309
   PubMed Web of Science ®Google Scholar
• Varol F, Uzunoglu R, Erbas H. Sut N,  Sayin C. VEGFR-1, Bcl-2, and HO-1 ratios in pregnant women with hypertension. Clin Appl Thrombosis/Hemostasis. 2013; 21(3):1–4
   Web of Science ®Google Scholar
• Karthikeyan VJ, Lip GY, Baghdadi S, Lane DA, Beevers DG, Blaan AD. Angiogenin and hemeoxygenase in pregnancy: influence of hypertension. Angiology. 2012; 63: 194–98.10.1177/0003319711410308
   PubMed Web of Science ®Google Scholar
• Erdemli HK, Yıldırımlar P, Alper TY, Kocabaş R, Salis O, Bedir A. Increased serum heme oxygenase-1 levels as a diagnostic marker of oxidative stress in preeclampsia. Hypertens Pregnancy. 2014; 334: 488–97. 10.3109/10641955.2014.946613
   PubMed Web of Science ®Google Scholar
• Vitoratos N, Papakonstantinou K, Deliveliotou A, Economou E, Panoulis C, Hassiakos D, Creatsas GK. Antepartum and postpartum serum heme oxygenase-1 levels in preeclamptic and normotensive pregnant women. In Vivo. 2011; 25: 445–50
   PubMed Web of Science ®Google Scholar
• Wantania JJ, Homenta C, Kepel BJ. Relationship of heme oxygenase-1 (HO-1) level with onset and severity in normotensive pregnancy and severe preeclampsia. Bali Med J. 2016; 51: 118–2210.15562/bmj.v5i1.267
   Web of Science ®Google Scholar
• Agarwal A, Mellado AA, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012; 10: 49
   PubMed Web of Science ®Google Scholar